The tubular hypothesis of nephron filtration and diabetic kidney disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The tubular hypothesis of nephron filtration and diabetic kidney disease
Authors
Keywords
-
Journal
Nature Reviews Nephrology
Volume 16, Issue 6, Pages 317-336
Publisher
Springer Science and Business Media LLC
Online
2020-03-09
DOI
10.1038/s41581-020-0256-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Sodium Glucose Cotransporter 2 Attenuates the Dysregulation of Kelch-Like 3 and NaCl Cotransporter in Obese Diabetic Mice
- (2019) Kenichi Ishizawa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Macula Densa SGLT1-NOS1-Tubuloglomerular Feedback Pathway, a New Mechanism for Glomerular Hyperfiltration during Hyperglycemia
- (2019) Jie Zhang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus
- (2019) Eri T. Kato et al. CIRCULATION
- Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
- (2019) Chiara Maria Assunta Cefalo et al. Cardiovascular Diabetology
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- How do Kidneys Adapt to a Deficit or Loss in Nephron Number?
- (2019) Hadi Fattah et al. PHYSIOLOGY
- Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging
- (2019) Kengo Kidokoro et al. CIRCULATION
- 243-OR: ADA Presidents' Select Abstract: Dapagliflozin Reduces Measured GFR by Reducing Renal Efferent Arteriolar Resistance in Type 2 Diabetes
- (2019) ERIK J. VAN BOMMEL et al. DIABETES
- Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen
- (2019) Rany M. Salem et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients with Type 2 Diabetes and Chronic Kidney Disease According to Baseline HbA1c, Including Those with HbA1c
- (2019) Christopher P. Cannon et al. CIRCULATION
- Preventing and Treating Heart Failure with Sodium-Glucose Co-Transporter 2 Inhibitors
- (2019) Muthiah Vaduganathan et al. AMERICAN JOURNAL OF CARDIOLOGY
- Renal Effects of Sodium-Glucose Co-Transporter Inhibitors
- (2019) Scott C. Thomson et al. AMERICAN JOURNAL OF CARDIOLOGY
- SGLT2 inhibition and kidney protection
- (2018) Josselin Nespoux et al. CLINICAL SCIENCE
- A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
- (2018) Natalie R. van Zuydam et al. DIABETES
- Sotagliflozin: a dual sodium-glucose co-transporter-1 and -2 inhibitor for the management of Type 1 and Type 2 diabetes mellitus
- (2018) H. Sims et al. DIABETIC MEDICINE
- Development of SGLT1 and SGLT2 inhibitors
- (2018) Timo Rieg et al. DIABETOLOGIA
- Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease
- (2018) Menno Pruijm et al. KIDNEY INTERNATIONAL
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy
- (2017) Xiaoxin X. Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy
- (2017) Liad Hinden et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment
- (2017) Lennart Tonneijck et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- CV Protection in the EMPA-REG OUTCOME Trial: A “Thrifty Substrate” Hypothesis
- (2016) Ele Ferrannini et al. DIABETES CARE
- JAK inhibition in the treatment of diabetic kidney disease
- (2016) Frank C. Brosius et al. DIABETOLOGIA
- Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition
- (2016) Volker Vallon et al. DIABETOLOGIA
- Uric acid in metabolic syndrome: From an innocent bystander to a central player
- (2016) Mehmet Kanbay et al. European Journal of Internal Medicine
- Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus
- (2016) Panai Song et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Inhibition of Nitric Oxide Synthase 1 Induces Salt-Sensitive Hypertension in Nitric Oxide Synthase 1α Knockout and Wild-Type MiceNovelty and Significance
- (2016) Ximing Wang et al. HYPERTENSION
- Renal epithelium regulates erythropoiesis via HIF-dependent suppression of erythropoietin
- (2016) Navid M. Farsijani et al. JOURNAL OF CLINICAL INVESTIGATION
- The effect of dapagliflozin on renal function in patients with type 2 diabetes
- (2016) Donald Elliott Kohan et al. JOURNAL OF NEPHROLOGY
- Mitochondrial Pathology and Glycolytic Shift during Proximal Tubule Atrophy after Ischemic AKI
- (2016) R. Lan et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- MAP17 Is a Necessary Activator of Renal Na+/Glucose Cotransporter SGLT2
- (2016) Michael J. Coady et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects
- (2016) Hiddo J. L. Heerspink et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
- (2015) Volker Vallon Annual Review of Medicine
- Renal effects of canagliflozin in type 2 diabetes mellitus
- (2015) Vlado Perkovic et al. CURRENT MEDICAL RESEARCH AND OPINION
- Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences
- (2015) Linda A Gallo et al. Diabetes & Vascular Disease Research
- Macula Densa Nitric Oxide Synthase 1 Protects against Salt-Sensitive Hypertension
- (2015) Y. Lu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes
- (2015) Vasilios Papademetriou et al. KIDNEY INTERNATIONAL
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diabetic kidney disease
- (2015) Merlin C. Thomas et al. Nature Reviews Disease Primers
- SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
- (2014) Yukihiro Chino et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
- (2014) Aurora Merovci et al. JOURNAL OF CLINICAL INVESTIGATION
- Molecular mechanisms of diabetic kidney disease
- (2014) Kimberly Reidy et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
- (2014) Ele Ferrannini et al. JOURNAL OF CLINICAL INVESTIGATION
- Functional Role of Glucose Metabolism, Osmotic Stress, and Sodium-Glucose Cotransporter Isoform-Mediated Transport on Na+/H+ Exchanger Isoform 3 Activity in the Renal Proximal Tubule
- (2014) T. D. Pessoa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Do Tubular Changes in the Diabetic Kidney Affect the Susceptibility to Acute Kidney Injury?
- (2014) Volker Vallon NEPHRON CLINICAL PRACTICE
- Localizations of Na+-d-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart
- (2014) Ivana Vrhovac et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial
- (2014) Anthony H Barnett et al. Lancet Diabetes & Endocrinology
- GLUT1 Regulation of the Pro-Sclerotic Mediators of Diabetic Nephropathy
- (2013) Charles W. Heilig et al. AMERICAN JOURNAL OF NEPHROLOGY
- Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
- (2013) David Z.I. Cherney et al. CIRCULATION
- Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes
- (2013) R. A. DeFronzo et al. DIABETES CARE
- Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials
- (2013) M. Monami et al. DIABETES OBESITY & METABOLISM
- Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
- (2013) H. J. Lambers Heerspink et al. DIABETES OBESITY & METABOLISM
- Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
- (2013) J.-F. Yale et al. DIABETES OBESITY & METABOLISM
- Hypoxia-inducible Factor-1α (HIF-1α) Protein Diminishes Sodium Glucose Transport 1 (SGLT1) and SGLT2 Protein Expression in Renal Epithelial Tubular Cells (LLC-PK1) under Hypoxia
- (2013) Juan R. Zapata-Morales et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Chronic kidney disease: global dimension and perspectives
- (2013) Vivekanand Jha et al. LANCET
- Regulation of the human Na+-dependent glucose cotransporter hSGLT2
- (2012) Chiara Ghezzi et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Expression of Na+-d-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences
- (2012) Ivan Sabolić et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Improved glycemic control in mice lacking Sglt1 and Sglt2
- (2012) David R. Powell et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Effects of SGLT2 inhibitors on cardiovascular outcomes
- (2012) Celine Foote et al. Diabetes & Vascular Disease Research
- The proximal tubule in the pathophysiology of the diabetic kidney
- (2011) Volker Vallon AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat
- (2011) Scott C. Thomson et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
- (2011) Yashpal S. Kanwar et al. Annual Review of Pathology-Mechanisms of Disease
- Renal Function in Diabetic Disease Models: The Tubular System in the Pathophysiology of the Diabetic Kidney
- (2011) Volker Vallon et al. Annual Review of Physiology
- Na+-D-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose Absorption and Glucose-Dependent Incretin Secretion
- (2011) V. Gorboulev et al. DIABETES
- SGLT2 Deletion Improves Glucose Homeostasis and Preserves Pancreatic β-Cell Function
- (2011) Michael J. Jurczak et al. DIABETES
- Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes
- (2011) E. I. Ekinci et al. DIABETES CARE
- The Association Between Dietary Sodium Intake, ESRD, and All-Cause Mortality in Patients With Type 1 Diabetes
- (2011) M. C. Thomas et al. DIABETES CARE
- The Tuberin/mTOR Pathway Promotes Apoptosis of Tubular Epithelial Cells in Diabetes
- (2011) C. Velagapudi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function
- (2011) Frank A. Holtkamp et al. KIDNEY INTERNATIONAL
- Biology of Human Sodium Glucose Transporters
- (2011) Ernest M. Wright et al. PHYSIOLOGICAL REVIEWS
- Transition of kidney tubule cells to a senescent phenotype in early experimental diabetes
- (2010) Joseph Satriano et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- The novel sodium glucose transporter 2 inhibitor dapagliflozin sustains pancreatic function and preserves islet morphology in obese, diabetic rats
- (2010) F. R. Macdonald et al. DIABETES OBESITY & METABOLISM
- D-Glucose Acts via Sodium/Glucose Cotransporter 1 to Increase NHE3 in Mouse Jejunal Brush Border by a Na+/H+ Exchange Regulatory Factor 2–Dependent Process
- (2010) Rong Lin et al. GASTROENTEROLOGY
- SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule
- (2010) V. Vallon et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Glomerular hyperfiltration and increased proximal sodium reabsorption in subjects with type 2 diabetes or impaired fasting glucose in a population of the African region
- (2010) M. Pruijm et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease
- (2010) Vincent Rigalleau et al. BMC Nephrology
- Influence of metformin on GLUT1 gene and protein expression in rat streptozotocindiabetes mellitusmodel
- (2010) Jelizaveta Sokolovska et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Salt-resistant blood pressure and salt-sensitive renal autoregulation in chronic streptozotocin diabetes
- (2009) Catherine Lau et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Familial Renal Glucosuria and SGLT2: From a Mendelian Trait to a Therapeutic Target
- (2009) R. Santer et al. Clinical Journal of the American Society of Nephrology
- Effect of treatment with losartan on salt sensitivity and SGLT2 expression in hypertensive diabetic rats
- (2009) Horacio Osorio et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis
- (2009) G. M. Magee et al. DIABETOLOGIA
- The role of tubular injury in diabetic nephropathy
- (2009) Caroline Jane Magri et al. European Journal of Internal Medicine
- Role of Growth Factors in Diabetic Kidney Disease
- (2009) F. Chiarelli et al. HORMONE AND METABOLIC RESEARCH
- SLC2A2 gene expression in kidney of diabetic rats is regulated by HNF-1α and HNF-3β
- (2009) H.S. Freitas et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Adenosine A1 Receptors Determine Glomerular Hyperfiltration and the Salt Paradox in Early Streptozotocin Diabetes Mellitus
- (2009) Volker Vallon et al. NEPHRON PHYSIOLOGY
- Effects of Nitric Oxide and Antioxidants on Advanced Glycation End Products-Induced Hypertrophic Growth in Human Renal Tubular Cells
- (2009) Jau-Shyang Huang et al. TOXICOLOGICAL SCIENCES
- Revised immunolocalization of the Na+-d-glucose cotransporter SGLT1 in rat organs with an improved antibody
- (2008) Daniela Balen et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Sugar Absorption in the Intestine: The Role of GLUT2
- (2008) George L. Kellett et al. Annual Review of Nutrition
- Inflammatory signaling and cellular senescence
- (2008) Jian-Lin Ren et al. CELLULAR SIGNALLING
- Lack of A1 Adenosine Receptors Augments Diabetic Hyperfiltration and Glomerular Injury
- (2008) R. Faulhaber-Walter et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mechanisms of Disease: the hypoxic tubular hypothesis of diabetic nephropathy
- (2008) Dhruv K Singh et al. Nature clinical practice. Nephrology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now